Drug substanceA national high-tech enterprise in the field of biomedicine

We provide manufacturing services for development and production of small molecule APIs. We use our chemistry expertise to ensure material supply for early development programs from China GMP facilities, with later stage and commercialization capacity focused in China. 

Our multi-purpose GMP-kilo lab, pilot plants and manufacturing plants are capable of handling advanced intermediates and complex APIs.  The facilities are equipped with glass-lined/stainless steel reactors with sizes ranging from 20 – 8,000 L.

Chemistry capabilities include asymmetric hydrogenations, air and moisture sensitive reactions, transitional metal catalysis reactions, high/low temperatures, high pressure and oxidations/reduction reactions. In our China-based facilities, we have completed some GMP APIs to support Phase l/ll/lll clinical trials in US, Europe and China.